Stay updated on Radiation Therapy Combo in Newly Diagnosed GBM Clinical Trial
Sign up to get notified when there's something new on the Radiation Therapy Combo in Newly Diagnosed GBM Clinical Trial page.

Latest updates to the Radiation Therapy Combo in Newly Diagnosed GBM Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe revision label on the page was updated from v3.6.5 to v3.6.6, indicating an administrative update to the trial details entry.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check34 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, indicating an administrative update to the ClinicalTrials.gov page. This change does not modify study content, eligibility criteria, or user-facing information.SummaryDifference0.0%

- Check48 days agoChange DetectedThe study record version was updated from v3.6.3 to v3.6.4, indicating a small documentation update. It does not reflect changes to eligibility, endpoints, or treatment.SummaryDifference0.0%

- Check62 days agoChange DetectedPublications section added with a citation to the Pembrolizumab, Temozolomide and HSPPC-96 vaccine study in newly diagnosed GBM, and a note that entries are auto-filled from PubMed.SummaryDifference0.2%

- Check70 days agoChange DetectedThe page’s revision tag was updated from v3.6.2 to v3.6.3, signaling a new release of the page’s content rather than a change to its substantive information.SummaryDifference0.0%

- Check77 days agoChange DetectedThe page's revision label was updated from v3.6.0 to v3.6.2, indicating a new version of the page.SummaryDifference0.0%

Stay in the know with updates to Radiation Therapy Combo in Newly Diagnosed GBM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Radiation Therapy Combo in Newly Diagnosed GBM Clinical Trial page.